GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN TYPE 2 DIABETES MELLITUS (T2DM): DATA FROM A REAL WORLD STUDY IN SPAIN

被引：0
|
作者：
Norrbacka, K. [1 ]
Sicras-Mainar, A. [2 ]
Hernandez, I [3 ]
Tofe-Povedano, S. [4 ]
Diaz Cerezo, S. [5 ]
Artime, E. [5 ]
Lebrec, J. [6 ]
Romera, I [5 ]
机构：
[1] Eli Lilly & Co, Helsinki, Finland
[2] Real Life Data SLU, Barcelona, Spain
[3] Real Life Data SLU, Madrid, Spain
[4] Univ Hosp Son Espases Palma de Mallorca, Palma De Mallorca, Spain
[5] Lilly Spain, Alcobendas, Spain
[6] HaaPACS GmbH, Schriesheim, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB119
引用
收藏
页码：S594 / S594
页数：1
相关论文
共 50 条
  • [21] Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development
    Ahren, Bo
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 196 - 201
  • [22] Glucagon-like Peptide-1 Receptor Agonists Prescribing Patterns in Youth with Type 2 Diabetes
    Bensignor, Megan
    Kelly, Aaron
    Wolfe, Jack
    Rudser, Kyle
    Arslanian, Silva
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 81 - 82
  • [23] Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
    Watchorn, David
    O'Shea, Donal
    Butler, Marcus W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (07) : 923 - 924
  • [24] Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: Differences and similarities
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (05) : 407 - 414
  • [25] Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
    Gentilella, Raffaella
    Pechtner, Valeria
    Corcos, Antonella
    Consoli, Agostino
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (01)
  • [26] Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
    Lovshin, Julie A.
    CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) : 524 - 535
  • [27] Kidney Outcomes With Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes
    Mosenzon, Ofri
    Schechter, Meir
    Leibowitz, Gil
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2021, 28 (04) : 347 - 360
  • [28] The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes
    Yin, Win L.
    Bain, Steve C.
    Min, Thinzar
    DIABETES THERAPY, 2020, 11 (04) : 835 - 844
  • [29] Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
    Tran, Kelvin Lingjet
    Park, Young In
    Pandya, Shalin
    Muliyil, Navin John
    Jensen, Brandon David
    Huynh, Kovin
    Nguyen, Quang T.
    AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (04): : 178 - 187
  • [30] Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
    Kim, Hyun Jin
    Park, Seok O.
    Ko, Seung-Hyun
    Rhee, Sang Youl
    Hur, Kyu-Yeon
    Kim, Nan-Hee
    Moon, Min Kyong
    Lee, Byung-Wan
    Kim, Jin Hwa
    Choi, Kyung Mook
    DIABETES & METABOLISM JOURNAL, 2017, 41 (06) : 423 - 429
12345